KN5505

N/A

Report date: 2025/11/06 17:16:10

First In Class

Base Information

Drug NameKN5505

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsOthers

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesShenzhen Rui Therapeutics Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Rui Therapeutics Co Ltd

Inactive CompaniesN/A

Active IndicationsOthers

Inactive IndicationsN/A

Other Information

ATC CodeN/A